These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36066404)

  • 21. Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine.
    Spencer BW; Prainsack B; Rujescu D; Giegling I; Collier DA; Gaughran F; MacCabe JH; Barr CL; Sigurdsson E; Stovring H; Malhotra AK; Curran SR;
    Pharmacogenomics; 2013 Nov; 14(15):1907-14. PubMed ID: 24236489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
    Vasudev K; Choi YH; Norman R; Kim RB; Schwarz UI
    Can J Psychiatry; 2017 Feb; 62(2):138-149. PubMed ID: 27681143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual atropine in the treatment of clozapine-induced sialorrhea.
    Matos Santana TE; Capurso NA; Ranganathan M; Yoon G
    Schizophr Res; 2017 Apr; 182():144-145. PubMed ID: 27816262
    [No Abstract]   [Full Text] [Related]  

  • 25. Clozapine and long-acting injectable antipsychotic combination: A retrospective one-year mirror-image study.
    Souaiby L; Gauthier C; Rieu C; Krebs MO; Advenier-Iakovlev E; Gaillard R
    Schizophr Res; 2017 Oct; 188():89-91. PubMed ID: 28139358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.
    Ignjatović Ristić D; Cohen D; Obradović A; Nikić-Đuričić K; Drašković M; Hinić D
    Nord J Psychiatry; 2018 Feb; 72(2):124-129. PubMed ID: 29125018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine Use in a Cohort of First-Episode Psychosis.
    Doyle R; Behan C; OʼKeeffe D; Masterson S; Kinsella A; Kelly A; Sheridan A; Keating D; Hynes C; Madigan K; Lawlor E; Clarke M
    J Clin Psychopharmacol; 2017 Oct; 37(5):512-517. PubMed ID: 28650930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pedal edema associated with clozapine use.
    Durst R; Raskin S; Katz G; Zislin J; Durst R
    Isr Med Assoc J; 2000 Jun; 2(6):485-6. PubMed ID: 10897248
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine-Induced Myocarditis: The Heartfelt Silent Assassin.
    Deardorff OG; Conklin TM; Hopkins TM; Hall LR; Trout MG; Cafer J
    Prim Care Companion CNS Disord; 2018 Oct; 20(5):. PubMed ID: 30326189
    [No Abstract]   [Full Text] [Related]  

  • 31. A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapy.
    Orsolini L; Bellagamba S; Salvi V; Volpe U
    Asian J Psychiatr; 2022 Jun; 72():103121. PubMed ID: 35427934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Clozapine in persons with a history of seizures: A retrospective study.
    Grover S; Sood A; Chakrabarti S
    Asian J Psychiatr; 2024 Aug; 98():104144. PubMed ID: 38955034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 37. Safe use of Clozapine in a patient with treatment resistant schizophrenia with co-morbid Dilated cardiomyopathy: A case report.
    Grover S; Sahoo S; Mehra A
    Asian J Psychiatr; 2022 Feb; 68():102971. PubMed ID: 34953217
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment.
    Garriga M; Mallorquí A; Bernad S; Ruiz-Cortes V; Oliveira C; Amoretti S; Mezquida G; Bioque M; Molina O; Gómez-Ramiro M; Vieta E; Bernardo M; Parellada E; García-Rizo C
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):75-80. PubMed ID: 34928563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marked liver enzyme elevations with clozapine.
    Markowitz JS; Grinberg R; Jackson C
    J Clin Psychopharmacol; 1997 Feb; 17(1):70-1. PubMed ID: 9004073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.